S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 161 to 180 of 7,543

Issue Date	Title / Author(s) / Citation	File
2014-11	A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Oncologist, Vol.19 No.11, pp.1129-1130	DOI
2023-10	A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study) Ang, Yvonne L. E.; Zhao, Xiaotian; Reungwetwattana, Thanyanan; Cho, Byoung-Chul; Liao, Bin-Chi; Yeung, Rebecca; Loong, Herbert H.; Kim, Dong-Wan; Yang, James Chih-Hsin; Lim, Sun Min; Ahn, Myung-Ju; Lee, Se-Hoon; Suwatanapongched, Thitiporn; Kongchauy, Kanchaporn; Ou, Qiuxiang; Yu, Ruoying; Tai, Bee Choo; Goh, Boon Cher; Mok, Tony S. K.; Soo, Ross A. Cancers, Vol.15 No.20, p. 4999	DOI
2019-10	A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer Kim, Yu-Jung; Keam, Bhumsuk; Ock, Chan-Young; Song, Sanghoon; Kim, Miso; Kim, Se Hyun; Kim, Ki Hwan; Kim, Jin-Soo; Kim, Tae Min; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Lung Cancer, Vol.136, pp.122-128	DOI
2012-06	A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research Oh, Do-Youn; Lee, Keun Wook; Lee, Kyung-Hee; Sohn, Chang-Hak; Park, Young Suk; Zang, Dae Young; Ryoo, Hun-Mo; Song, Hong-Suk; Kim, Jin-Soo; Kang, Hye-Jin; Kim, Bong-Seog; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.3, pp.1164-1174	DOI
2019-01	A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma Kim, Miso; Kim, Tae Min; Keam, Bhumsuk; Kim, Yu Jung; Paeng, Jin Chul; Moon, Kyung Chul; Kim, Dong-Wan; Heo, Dae Seog Oncologist, Vol.24 No.1, pp.20-29	DOI
2008-01	A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer Kim, Y. J.; Im, S. -A.; Kim, H. G.; Oh, S. Y.; Lee, K. W.; Choi, I. S.; Oh, D. Y.; Lee, S. H.; Kim, J. H.; Kim, D. W.; Kim, T. Y.; Kim, S. W.; Heo, D. S.; Yoon, Y. B.; Bang, Y. J. Annals of Oncology, Vol.19 No.1, pp.99-103	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2023-04	A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03) Lee, Dae-Won; Keam, Bhumsuk; Lee, Keun Seok; Ahn, Jin-Hee; Sohn, Joohyuk; Ahn, Jin Seok; Lee, Moon Hee; Kim, Jee Hyun; Lee, Kyung Eun; Kim, Hyo Jung; Kim, Si-Young; Park, Yeon Hee; Ock, Chan-Young; Lee, Kyung-Hun; Han, Sae-Won; Kim, Sung-Bae; Im, Young Hyuck; Chung, Hyun Cheol; Oh, Do-Youn; Im, Seock-Ah Cancer Research and Treatment, Vol.55 No.2, pp.523-530	DOI
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2022-07	A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN) Lee, Yong Jae; Seol, Aeran; Lee, Maria; Kim, Jae-Weon; Kim, Hee Seung; Kim, Kidong; Suh, Dong Hoon; Kim, Sunghoon; Kim, Sang Wun; Lee, Jung-Yun In Vivo, Vol.36 No.4, pp.1949-1958	DOI
2019-02	A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer Bang, Y. -J.; Kang, Y. -K.; Ng, M.; Chung, H. C.; Wainberg, Z. A.; Gendreau, S.; Chan, W. Y.; Xu, N.; Maslyar, D.; Meng, R.; Chau, I; Ajani, J. A. European Journal of Cancer, Vol.108, pp.17-24	DOI
2014-08	A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer Kang, Y-K; Rha, S. Y.; Tassone, P.; Barriuso, J.; Yu, R.; Szado, T.; Garg, A.; Bang, Y-J British Journal of Cancer, Vol.111 No.4, pp.660-666	DOI
2002-11	A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer Chang, HM; Jung, KH; Kim, TY; Kim, WS; Yang, HK; Lee, KU; Choe, KJ; Heo, DS; Bang, YJ; Kim, NK Annals of Oncology, Vol.13 No.11, pp.1779-1785	DOI
2002-06	A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer Kim, Tae-You; Yang, Sung Hyun; Lee, Se Hoon; Park, Young-Seok; Im, Yung Hyuck; Kang, Won-Ki; Ha, Sung Hwan; Park, Chan Il; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong American Journal of Clinical Oncology, Vol.25 No.3, pp.238-243	DOI
2018-04	A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results Pivot, X.; Bondarenko, I.; Nowecki, Z.; Dvorkin, M.; Trishkina, E.; Ahn, J. H.; Im, S. A.; Sarosiek, T.; Chatterjee, S.; Wojtukiewicz, M. Z.; Shparyk, Y.; Moiseyenko, V.; Bello, M., III; Semiglazov, V.; Lee, Y.; Lim, J. European Journal of Cancer, Vol.93, pp.19-27	DOI
2021-05	A pilot study comparing three bend angles for lighted stylet intubation Won, Dongwook; Lee, Jung-Man; Lee, Jiwon; Hwang, Jin-Young; Kim, Tae Kyong; Chang, Jee-Eun; Kim, Hyerim; Ma, Seoyoung; Min, Seong-Won BMC Anesthesiology. 2021 May 17;21(1):148	view file DOI
2015-02	A platform of integrative studies from in vitro to in vivo experiments: Towards drug development for ischemic retinopathy Jo, Dong Hyun; Kim, Jin Hyoung; Kim, Jeong Hun Biomedicine and Pharmacotherapy, Vol.69, pp.367-373	DOI
2015-02	A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo Lee, Young-Ho; Yoon, Hong Yeol; Shin, Jung Min; Saravanakumar, G.; Noh, Kyung Hee; Song, Kwon-Ho; Jeon, Ju-Hong; Kim, Dong-Wan; Lee, Kyung-Mi; Kim, Kwangmeyung; Kwon, Ick Chan; Park, Jae Hyung; Kim, Tae Woo Journal of Controlled Release, Vol.199, pp.98-105	DOI
2020	A population pharmacokinetic model of intravenous dexmedetomidine after pediatric brain surgery 송인경	view file link
2015-12	A Possible Association Between Thyroid Cancer and Breast Cancer An, Jee Hyun; Hwangbo, Yul; Ahn, Hwa Young; Keam, Bhumsuk; Lee, Kyu Eun; Han, Wonshik; Park, Do Joon; Park, In Ae; Noh, Dong-Young; Youn, Yeo-Kyu; Cho, Bo Youn; Im, Seock-Ah; Park, Young Joo Thyroid, Vol.25 No.12, pp.1330-1338	DOI

1 5 6 7 8 9 10 11 378